Rob Spencer

COO

Equibles does not estimate personal net worth.

Get an email with a short summary when Kura Oncology, Inc. publishes a filing, an earnings call transcript or a press release.

Get KURA alerts

About Rob Spencer

Rob Spencer is recorded as COO at Kura Oncology, Inc. (KURA). Rob Spencer has spoken on 1 investor event across 1 company, most recently for Kura Oncology, Inc. on October 13, 2026. Kura Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kura Oncology, Inc. includes Troy Wilson (CEO), Jennifer Fulk (CFO), Troy E. Wilson, Ph.D., J.D. (CFO and Board Member) and 7 others.

Rob Spencer on recent calls

“So Caspian's initial development objective is to characterize the safety, tolerability, and pharmacokinetic profile of KO7246 for chronic administration and to assess its ability to improve endogenous insulin production in people with diabetes.”

COO, Kura Oncology EASD Virtual Investor Event · October 13, 2026